Depomed, Inc. (NASDAQ: DEPO) announced today it has received guidance from the FDA in formal meeting minutes from a meeting ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE